Wells Fargo & Company XERIS PHARMACEUTICALS INC Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
N/A
-2,566 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
N/A
1,000 Added 63.86%
2,566 $6,000
Q2 2021

Aug 16, 2021
SELL
N/A
-8,398 Reduced 84.28%
1,566 $6,000
Q1 2021

May 13, 2021
SELL
N/A
-33,827 Reduced 77.25%
9,964 $45,000
Q4 2020

Feb 09, 2021
BUY
N/A
18,204 Added 71.15%
43,791 $215,000
Q3 2020

Nov 05, 2020
SELL
N/A
-9,154 Reduced 26.35%
25,587 $151,000
Q2 2020

Aug 13, 2020
BUY
N/A
9,816 Added 39.38%
34,741 $93,000
Q1 2020

May 14, 2020
BUY
N/A
24,925 New
24,925 $49,000
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email